Occult Hypercalcemia Unmasked: Insights From Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Syndrome Associated With a Gastrointestinal Lymphoma Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.7759/cureus.95228
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is a rare inflammatory arthritis that may present as a paraneoplastic syndrome. We report a case of a 51-year-old woman who initially responded to high-dose steroids for RS3PE but later developed persistent hypercalcemia. Serum calcium ranged from 3.03 to 4.02 mmol/L, with suppressed parathyroid hormone (PTH), suggesting a non-parathyroid cause. Despite initial suspicion of infection-related hypercalcemia, calcium levels remained elevated after antimicrobial therapy. The 25-hydroxyvitamin D level was elevated, although serum 1,25-dihydroxyvitamin D was not directly measured. Immunohistochemistry revealed strong expression of parathyroid hormone-related protein (PTHrP) and 25-hydroxyvitamin D3-1α-hydroxylase (CYP27B1), indicating potential contributions from both humoral and vitamin D-mediated pathways. The patient received supportive treatment with diuretics, calcitonin, and denosumab, which successfully corrected hypercalcemia. Gastrointestinal endoscopy and biopsy ultimately confirmed diffuse large B-cell lymphoma (DLBCL). She then underwent anti-lymphoma chemotherapy, resulting in sustained remission and stable calcium levels. This case highlights the diagnostic challenges of RS3PE with hypercalcemia and the importance of considering underlying malignancy when standard therapy fails. It also demonstrates that PET-CT may fail to detect tumors in hollow organs and that gastrointestinal endoscopy should be considered in unresolved cases. Early recognition of tumor-associated hypercalcemia and a mechanism-based diagnostic approach are essential for effective treatment.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.7759/cureus.95228
- https://www.cureus.com/articles/406891-occult-hypercalcemia-unmasked-insights-from-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-associated-with-a-gastrointestinal-lymphoma.pdf
- OA Status
- diamond
- References
- 18
- OpenAlex ID
- https://openalex.org/W4415478470
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415478470Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.7759/cureus.95228Digital Object Identifier
- Title
-
Occult Hypercalcemia Unmasked: Insights From Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Syndrome Associated With a Gastrointestinal LymphomaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-23Full publication date if available
- Authors
-
Zheng Xiang, Yuying Yang, Weiwei Rui, Jialin Teng, Yutong SuList of authors in order
- Landing page
-
https://doi.org/10.7759/cureus.95228Publisher landing page
- PDF URL
-
https://www.cureus.com/articles/406891-occult-hypercalcemia-unmasked-insights-from-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-associated-with-a-gastrointestinal-lymphoma.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.cureus.com/articles/406891-occult-hypercalcemia-unmasked-insights-from-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-associated-with-a-gastrointestinal-lymphoma.pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
18Number of works referenced by this work
Full payload
| id | https://openalex.org/W4415478470 |
|---|---|
| doi | https://doi.org/10.7759/cureus.95228 |
| ids.doi | https://doi.org/10.7759/cureus.95228 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41287694 |
| ids.openalex | https://openalex.org/W4415478470 |
| fwci | 0.0 |
| type | article |
| title | Occult Hypercalcemia Unmasked: Insights From Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Syndrome Associated With a Gastrointestinal Lymphoma |
| biblio.issue | 10 |
| biblio.volume | 17 |
| biblio.last_page | e95228 |
| biblio.first_page | e95228 |
| topics[0].id | https://openalex.org/T12209 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2732 |
| topics[0].subfield.display_name | Orthopedics and Sports Medicine |
| topics[0].display_name | Bone and Joint Diseases |
| topics[1].id | https://openalex.org/T11571 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9994999766349792 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2737 |
| topics[1].subfield.display_name | Physiology |
| topics[1].display_name | Sarcoidosis and Beryllium Toxicity Research |
| topics[2].id | https://openalex.org/T13759 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9987000226974487 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Medical Imaging and Pathology Studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.7759/cureus.95228 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2738950867 |
| locations[0].source.issn | 2168-8184 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2168-8184 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Cureus |
| locations[0].source.host_organization | https://openalex.org/P4310316779 |
| locations[0].source.host_organization_name | Cureus, Inc. |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310316779 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.cureus.com/articles/406891-occult-hypercalcemia-unmasked-insights-from-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-associated-with-a-gastrointestinal-lymphoma.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Cureus |
| locations[0].landing_page_url | https://doi.org/10.7759/cureus.95228 |
| locations[1].id | pmid:41287694 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Cureus |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41287694 |
| locations[2].id | pmh:oai:europepmc.org:11447221 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12640427 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5033801352 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-8161-5194 |
| authorships[0].author.display_name | Zheng Xiang |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I183067930, https://openalex.org/I2801556517 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN. |
| authorships[0].institutions[0].id | https://openalex.org/I2801556517 |
| authorships[0].institutions[0].ror | https://ror.org/01hv94n30 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2801556517 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Ruijin Hospital |
| authorships[0].institutions[1].id | https://openalex.org/I183067930 |
| authorships[0].institutions[1].ror | https://ror.org/0220qvk04 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I183067930 |
| authorships[0].institutions[1].country_code | CN |
| authorships[0].institutions[1].display_name | Shanghai Jiao Tong University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Zhihan Xiang |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN. |
| authorships[1].author.id | https://openalex.org/A5072887238 |
| authorships[1].author.orcid | https://orcid.org/0009-0002-4331-1418 |
| authorships[1].author.display_name | Yuying Yang |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I183067930, https://openalex.org/I2801556517 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN. |
| authorships[1].institutions[0].id | https://openalex.org/I2801556517 |
| authorships[1].institutions[0].ror | https://ror.org/01hv94n30 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2801556517 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | Ruijin Hospital |
| authorships[1].institutions[1].id | https://openalex.org/I183067930 |
| authorships[1].institutions[1].ror | https://ror.org/0220qvk04 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I183067930 |
| authorships[1].institutions[1].country_code | CN |
| authorships[1].institutions[1].display_name | Shanghai Jiao Tong University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Yuying Yang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN. |
| authorships[2].author.id | https://openalex.org/A5100297342 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Weiwei Rui |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I183067930, https://openalex.org/I2801556517 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN. |
| authorships[2].institutions[0].id | https://openalex.org/I2801556517 |
| authorships[2].institutions[0].ror | https://ror.org/01hv94n30 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I2801556517 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Ruijin Hospital |
| authorships[2].institutions[1].id | https://openalex.org/I183067930 |
| authorships[2].institutions[1].ror | https://ror.org/0220qvk04 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I183067930 |
| authorships[2].institutions[1].country_code | CN |
| authorships[2].institutions[1].display_name | Shanghai Jiao Tong University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Weiwei Rui |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN. |
| authorships[3].author.id | https://openalex.org/A5026549258 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1016-9064 |
| authorships[3].author.display_name | Jialin Teng |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I183067930, https://openalex.org/I2801556517 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN. |
| authorships[3].institutions[0].id | https://openalex.org/I2801556517 |
| authorships[3].institutions[0].ror | https://ror.org/01hv94n30 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2801556517 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Ruijin Hospital |
| authorships[3].institutions[1].id | https://openalex.org/I183067930 |
| authorships[3].institutions[1].ror | https://ror.org/0220qvk04 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I183067930 |
| authorships[3].institutions[1].country_code | CN |
| authorships[3].institutions[1].display_name | Shanghai Jiao Tong University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jialin Teng |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN. |
| authorships[4].author.id | https://openalex.org/A5089540622 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-0358-8933 |
| authorships[4].author.display_name | Yutong Su |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1299457549 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Rheumatology and Immunology, Shanghai Hospital of Civil Aviation Administration of China, Shanghai, CHN. |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I183067930, https://openalex.org/I2801556517 |
| authorships[4].affiliations[1].raw_affiliation_string | Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN. |
| authorships[4].institutions[0].id | https://openalex.org/I1299457549 |
| authorships[4].institutions[0].ror | https://ror.org/05gfwht30 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I1299457549, https://openalex.org/I4210127216 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Civil Aviation Administration of China |
| authorships[4].institutions[1].id | https://openalex.org/I2801556517 |
| authorships[4].institutions[1].ror | https://ror.org/01hv94n30 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I2801556517 |
| authorships[4].institutions[1].country_code | CN |
| authorships[4].institutions[1].display_name | Ruijin Hospital |
| authorships[4].institutions[2].id | https://openalex.org/I183067930 |
| authorships[4].institutions[2].ror | https://ror.org/0220qvk04 |
| authorships[4].institutions[2].type | education |
| authorships[4].institutions[2].lineage | https://openalex.org/I183067930 |
| authorships[4].institutions[2].country_code | CN |
| authorships[4].institutions[2].display_name | Shanghai Jiao Tong University |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Yutong Su |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN., Department of Rheumatology and Immunology, Shanghai Hospital of Civil Aviation Administration of China, Shanghai, CHN. |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.cureus.com/articles/406891-occult-hypercalcemia-unmasked-insights-from-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-associated-with-a-gastrointestinal-lymphoma.pdf |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-23T00:00:00 |
| display_name | Occult Hypercalcemia Unmasked: Insights From Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Syndrome Associated With a Gastrointestinal Lymphoma |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12209 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2732 |
| primary_topic.subfield.display_name | Orthopedics and Sports Medicine |
| primary_topic.display_name | Bone and Joint Diseases |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.7759/cureus.95228 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2738950867 |
| best_oa_location.source.issn | 2168-8184 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2168-8184 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Cureus |
| best_oa_location.source.host_organization | https://openalex.org/P4310316779 |
| best_oa_location.source.host_organization_name | Cureus, Inc. |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310316779 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.cureus.com/articles/406891-occult-hypercalcemia-unmasked-insights-from-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-associated-with-a-gastrointestinal-lymphoma.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Cureus |
| best_oa_location.landing_page_url | https://doi.org/10.7759/cureus.95228 |
| primary_location.id | doi:10.7759/cureus.95228 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2738950867 |
| primary_location.source.issn | 2168-8184 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2168-8184 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Cureus |
| primary_location.source.host_organization | https://openalex.org/P4310316779 |
| primary_location.source.host_organization_name | Cureus, Inc. |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310316779 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.cureus.com/articles/406891-occult-hypercalcemia-unmasked-insights-from-remitting-seronegative-symmetrical-synovitis-with-pitting-edema-rs3pe-syndrome-associated-with-a-gastrointestinal-lymphoma.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Cureus |
| primary_location.landing_page_url | https://doi.org/10.7759/cureus.95228 |
| publication_date | 2025-10-23 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4293858919, https://openalex.org/W4396658589, https://openalex.org/W4379094881, https://openalex.org/W4376641938, https://openalex.org/W1978862392, https://openalex.org/W2618114651, https://openalex.org/W4230457653, https://openalex.org/W2996622400, https://openalex.org/W2173934737, https://openalex.org/W2193356899, https://openalex.org/W3037654002, https://openalex.org/W4395072196, https://openalex.org/W3088448654, https://openalex.org/W2070636400, https://openalex.org/W2070058460, https://openalex.org/W1990962859, https://openalex.org/W4362607892, https://openalex.org/W4353083572 |
| referenced_works_count | 18 |
| abstract_inverted_index.D | 73, 80 |
| abstract_inverted_index.a | 9, 17, 22, 25, 55, 196 |
| abstract_inverted_index.It | 167 |
| abstract_inverted_index.We | 20 |
| abstract_inverted_index.as | 16 |
| abstract_inverted_index.be | 185 |
| abstract_inverted_index.in | 139, 177, 187 |
| abstract_inverted_index.is | 8 |
| abstract_inverted_index.of | 24, 61, 89, 152, 159, 192 |
| abstract_inverted_index.to | 31, 46, 174 |
| abstract_inverted_index.She | 133 |
| abstract_inverted_index.The | 71, 108 |
| abstract_inverted_index.and | 94, 104, 116, 124, 142, 156, 180, 195 |
| abstract_inverted_index.are | 200 |
| abstract_inverted_index.but | 36 |
| abstract_inverted_index.for | 34, 202 |
| abstract_inverted_index.may | 14, 172 |
| abstract_inverted_index.not | 82 |
| abstract_inverted_index.the | 149, 157 |
| abstract_inverted_index.was | 75, 81 |
| abstract_inverted_index.who | 28 |
| abstract_inverted_index.3.03 | 45 |
| abstract_inverted_index.4.02 | 47 |
| abstract_inverted_index.This | 146 |
| abstract_inverted_index.also | 168 |
| abstract_inverted_index.both | 102 |
| abstract_inverted_index.case | 23, 147 |
| abstract_inverted_index.fail | 173 |
| abstract_inverted_index.from | 44, 101 |
| abstract_inverted_index.rare | 10 |
| abstract_inverted_index.that | 13, 170, 181 |
| abstract_inverted_index.then | 134 |
| abstract_inverted_index.when | 163 |
| abstract_inverted_index.with | 4, 49, 113, 154 |
| abstract_inverted_index.Early | 190 |
| abstract_inverted_index.RS3PE | 35, 153 |
| abstract_inverted_index.Serum | 41 |
| abstract_inverted_index.after | 68 |
| abstract_inverted_index.edema | 6 |
| abstract_inverted_index.large | 129 |
| abstract_inverted_index.later | 37 |
| abstract_inverted_index.level | 74 |
| abstract_inverted_index.serum | 78 |
| abstract_inverted_index.which | 118 |
| abstract_inverted_index.woman | 27 |
| abstract_inverted_index.(PTH), | 53 |
| abstract_inverted_index.B-cell | 130 |
| abstract_inverted_index.PET-CT | 171 |
| abstract_inverted_index.biopsy | 125 |
| abstract_inverted_index.cases. | 189 |
| abstract_inverted_index.cause. | 57 |
| abstract_inverted_index.detect | 175 |
| abstract_inverted_index.fails. | 166 |
| abstract_inverted_index.hollow | 178 |
| abstract_inverted_index.levels | 65 |
| abstract_inverted_index.organs | 179 |
| abstract_inverted_index.ranged | 43 |
| abstract_inverted_index.report | 21 |
| abstract_inverted_index.should | 184 |
| abstract_inverted_index.stable | 143 |
| abstract_inverted_index.strong | 87 |
| abstract_inverted_index.tumors | 176 |
| abstract_inverted_index.(PTHrP) | 93 |
| abstract_inverted_index.(RS3PE) | 7 |
| abstract_inverted_index.Despite | 58 |
| abstract_inverted_index.calcium | 42, 64, 144 |
| abstract_inverted_index.diffuse | 128 |
| abstract_inverted_index.hormone | 52 |
| abstract_inverted_index.humoral | 103 |
| abstract_inverted_index.initial | 59 |
| abstract_inverted_index.levels. | 145 |
| abstract_inverted_index.mmol/L, | 48 |
| abstract_inverted_index.patient | 109 |
| abstract_inverted_index.pitting | 5 |
| abstract_inverted_index.present | 15 |
| abstract_inverted_index.protein | 92 |
| abstract_inverted_index.therapy | 165 |
| abstract_inverted_index.vitamin | 105 |
| abstract_inverted_index.(DLBCL). | 132 |
| abstract_inverted_index.although | 77 |
| abstract_inverted_index.approach | 199 |
| abstract_inverted_index.directly | 83 |
| abstract_inverted_index.elevated | 67 |
| abstract_inverted_index.lymphoma | 131 |
| abstract_inverted_index.received | 110 |
| abstract_inverted_index.remained | 66 |
| abstract_inverted_index.revealed | 86 |
| abstract_inverted_index.standard | 164 |
| abstract_inverted_index.steroids | 33 |
| abstract_inverted_index.therapy. | 70 |
| abstract_inverted_index.Remitting | 0 |
| abstract_inverted_index.arthritis | 12 |
| abstract_inverted_index.confirmed | 127 |
| abstract_inverted_index.corrected | 120 |
| abstract_inverted_index.developed | 38 |
| abstract_inverted_index.effective | 203 |
| abstract_inverted_index.elevated, | 76 |
| abstract_inverted_index.endoscopy | 123, 183 |
| abstract_inverted_index.essential | 201 |
| abstract_inverted_index.high-dose | 32 |
| abstract_inverted_index.initially | 29 |
| abstract_inverted_index.measured. | 84 |
| abstract_inverted_index.pathways. | 107 |
| abstract_inverted_index.potential | 99 |
| abstract_inverted_index.remission | 141 |
| abstract_inverted_index.responded | 30 |
| abstract_inverted_index.resulting | 138 |
| abstract_inverted_index.suspicion | 60 |
| abstract_inverted_index.sustained | 140 |
| abstract_inverted_index.syndrome. | 19 |
| abstract_inverted_index.synovitis | 3 |
| abstract_inverted_index.treatment | 112 |
| abstract_inverted_index.underwent | 135 |
| abstract_inverted_index.(CYP27B1), | 97 |
| abstract_inverted_index.D-mediated | 106 |
| abstract_inverted_index.challenges | 151 |
| abstract_inverted_index.considered | 186 |
| abstract_inverted_index.denosumab, | 117 |
| abstract_inverted_index.diagnostic | 150, 198 |
| abstract_inverted_index.diuretics, | 114 |
| abstract_inverted_index.expression | 88 |
| abstract_inverted_index.highlights | 148 |
| abstract_inverted_index.importance | 158 |
| abstract_inverted_index.indicating | 98 |
| abstract_inverted_index.malignancy | 162 |
| abstract_inverted_index.persistent | 39 |
| abstract_inverted_index.suggesting | 54 |
| abstract_inverted_index.supportive | 111 |
| abstract_inverted_index.suppressed | 50 |
| abstract_inverted_index.treatment. | 204 |
| abstract_inverted_index.ultimately | 126 |
| abstract_inverted_index.underlying | 161 |
| abstract_inverted_index.unresolved | 188 |
| abstract_inverted_index.51-year-old | 26 |
| abstract_inverted_index.calcitonin, | 115 |
| abstract_inverted_index.considering | 160 |
| abstract_inverted_index.parathyroid | 51, 90 |
| abstract_inverted_index.recognition | 191 |
| abstract_inverted_index.symmetrical | 2 |
| abstract_inverted_index.demonstrates | 169 |
| abstract_inverted_index.inflammatory | 11 |
| abstract_inverted_index.seronegative | 1 |
| abstract_inverted_index.successfully | 119 |
| abstract_inverted_index.anti-lymphoma | 136 |
| abstract_inverted_index.antimicrobial | 69 |
| abstract_inverted_index.chemotherapy, | 137 |
| abstract_inverted_index.contributions | 100 |
| abstract_inverted_index.hypercalcemia | 155, 194 |
| abstract_inverted_index.hypercalcemia, | 63 |
| abstract_inverted_index.hypercalcemia. | 40, 121 |
| abstract_inverted_index.paraneoplastic | 18 |
| abstract_inverted_index.hormone-related | 91 |
| abstract_inverted_index.mechanism-based | 197 |
| abstract_inverted_index.non-parathyroid | 56 |
| abstract_inverted_index.Gastrointestinal | 122 |
| abstract_inverted_index.gastrointestinal | 182 |
| abstract_inverted_index.tumor-associated | 193 |
| abstract_inverted_index.25-hydroxyvitamin | 72, 95 |
| abstract_inverted_index.infection-related | 62 |
| abstract_inverted_index.D3-1α-hydroxylase | 96 |
| abstract_inverted_index.Immunohistochemistry | 85 |
| abstract_inverted_index.1,25-dihydroxyvitamin | 79 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| citation_normalized_percentile.value | 0.66614999 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |